Teva Pharmaceutical Industries Limited provided earnings guidance for the year 2022. The company expects revenue to be in range of $15.6 billion to $16.2 billion, operating income to be in the range of $4.2 billion to $4.5 billion and EPS to be in the range of $2.40 to $2.60.